559 related articles for article (PubMed ID: 21907221)
21. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Autry AE; Adachi M; Nosyreva E; Na ES; Los MF; Cheng PF; Kavalali ET; Monteggia LM
Nature; 2011 Jun; 475(7354):91-5. PubMed ID: 21677641
[TBL] [Abstract][Full Text] [Related]
22. Sex Differences in the Temporal Neuromolecular and Synaptogenic Effects of the Rapid-acting Antidepressant Drug Ketamine in the Mouse Brain.
Thelen C; Flaherty E; Saurine J; Sens J; Mohamed S; Pitychoutis PM
Neuroscience; 2019 Feb; 398():182-192. PubMed ID: 30537521
[TBL] [Abstract][Full Text] [Related]
23. Synaptic mechanisms underlying rapid antidepressant action of ketamine.
Kavalali ET; Monteggia LM
Am J Psychiatry; 2012 Nov; 169(11):1150-6. PubMed ID: 23534055
[TBL] [Abstract][Full Text] [Related]
24. Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation.
Harraz MM; Tyagi R; Cortés P; Snyder SH
Mol Psychiatry; 2016 Mar; 21(3):313-9. PubMed ID: 26782056
[TBL] [Abstract][Full Text] [Related]
25. Role of mTOR1 signaling in the antidepressant effects of ketamine and the potential of mTORC1 activators as novel antidepressants.
Kato T
Neuropharmacology; 2023 Feb; 223():109325. PubMed ID: 36334763
[TBL] [Abstract][Full Text] [Related]
26. Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections.
Duman RS
Dialogues Clin Neurosci; 2014 Mar; 16(1):11-27. PubMed ID: 24733968
[TBL] [Abstract][Full Text] [Related]
27. Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections.
Duman RS
Depress Anxiety; 2014 Apr; 31(4):291-6. PubMed ID: 24616149
[TBL] [Abstract][Full Text] [Related]
28. Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms.
Kato T; Duman RS
Pharmacol Biochem Behav; 2020 Jan; 188():172827. PubMed ID: 31733218
[TBL] [Abstract][Full Text] [Related]
29. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
Yang C; Kobayashi S; Nakao K; Dong C; Han M; Qu Y; Ren Q; Zhang JC; Ma M; Toki H; Yamaguchi JI; Chaki S; Shirayama Y; Nakazawa K; Manabe T; Hashimoto K
Biol Psychiatry; 2018 Oct; 84(8):591-600. PubMed ID: 29945718
[TBL] [Abstract][Full Text] [Related]
30. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
[TBL] [Abstract][Full Text] [Related]
31. Akt mediates GSK-3β phosphorylation in the rat prefrontal cortex during the process of ketamine exerting rapid antidepressant actions.
Zhou W; Dong L; Wang N; Shi JY; Yang JJ; Zuo ZY; Zhou ZQ
Neuroimmunomodulation; 2014; 21(4):183-8. PubMed ID: 24504086
[TBL] [Abstract][Full Text] [Related]
32. Role of BDNF in the pathophysiology and treatment of depression: Activity-dependent effects distinguish rapid-acting antidepressants.
Duman RS; Deyama S; Fogaça MV
Eur J Neurosci; 2021 Jan; 53(1):126-139. PubMed ID: 31811669
[TBL] [Abstract][Full Text] [Related]
33. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C
Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
[TBL] [Abstract][Full Text] [Related]
34. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E
Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718
[TBL] [Abstract][Full Text] [Related]
35. Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway.
Pazini FL; Cunha MP; Rosa JM; Colla AR; Lieberknecht V; Oliveira Á; Rodrigues AL
Mol Neurobiol; 2016 Dec; 53(10):6818-6834. PubMed ID: 26660117
[TBL] [Abstract][Full Text] [Related]
36. Isoflurane produces antidepressant effects inducing BDNF-TrkB signaling in CUMS mice.
Zhang SS; Tian YH; Jin SJ; Wang WC; Zhao JX; Si XM; Zhang L; Xu H; Jin JY
Psychopharmacology (Berl); 2019 Nov; 236(11):3301-3315. PubMed ID: 31197433
[TBL] [Abstract][Full Text] [Related]
37. Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties.
Zunszain PA; Horowitz MA; Cattaneo A; Lupi MM; Pariante CM
Mol Psychiatry; 2013 Dec; 18(12):1236-41. PubMed ID: 23877835
[TBL] [Abstract][Full Text] [Related]
38. The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
Suzuki K; Monteggia LM
Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215
[TBL] [Abstract][Full Text] [Related]
39. Bridging rapid and sustained antidepressant effects of ketamine.
Kim JW; Suzuki K; Kavalali ET; Monteggia LM
Trends Mol Med; 2023 May; 29(5):364-375. PubMed ID: 36907686
[TBL] [Abstract][Full Text] [Related]
40. Guanosine as a promising target for fast-acting antidepressant responses.
Camargo A; Rodrigues ALS
Pharmacol Biochem Behav; 2022 Jul; 218():173422. PubMed ID: 35732211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
